Cargando…
Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated w...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566630/ https://www.ncbi.nlm.nih.gov/pubmed/28790025 http://dx.doi.org/10.2196/cancer.7443 |
_version_ | 1783258584107188224 |
---|---|
author | Groen, Wim G Kuijpers, Wilma Oldenburg, Hester SA Wouters, Michel WJM Aaronson, Neil K van Harten, Wim H |
author_facet | Groen, Wim G Kuijpers, Wilma Oldenburg, Hester SA Wouters, Michel WJM Aaronson, Neil K van Harten, Wim H |
author_sort | Groen, Wim G |
collection | PubMed |
description | BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months. Feasibility, usability, and preliminary impact (ie, patient activation, quality of life, and physical activity) were studied by means of questionnaires, a focus group, and analysis of user log data. RESULTS: We included 37 of 123 eligible patients (mean age 59.6 years). The majority of responses (82%) were positive about using MyAVL, 69% saw it as a valuable addition to care, and 56% perceived increased control over their health. No positive effects could be substantiated on the impact measures. CONCLUSIONS: MyAVL appears to be a feasible and user-friendly, multifunctional eHealth program for a selected group of lung cancer patients. However, it needs further improvements to positively impact patient outcomes. |
format | Online Article Text |
id | pubmed-5566630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-55666302017-09-07 Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study Groen, Wim G Kuijpers, Wilma Oldenburg, Hester SA Wouters, Michel WJM Aaronson, Neil K van Harten, Wim H JMIR Cancer Original Paper BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months. Feasibility, usability, and preliminary impact (ie, patient activation, quality of life, and physical activity) were studied by means of questionnaires, a focus group, and analysis of user log data. RESULTS: We included 37 of 123 eligible patients (mean age 59.6 years). The majority of responses (82%) were positive about using MyAVL, 69% saw it as a valuable addition to care, and 56% perceived increased control over their health. No positive effects could be substantiated on the impact measures. CONCLUSIONS: MyAVL appears to be a feasible and user-friendly, multifunctional eHealth program for a selected group of lung cancer patients. However, it needs further improvements to positively impact patient outcomes. JMIR Publications 2017-08-08 /pmc/articles/PMC5566630/ /pubmed/28790025 http://dx.doi.org/10.2196/cancer.7443 Text en ©Wim G Groen, Wilma Kuijpers, Hester SA Oldenburg, Michel WJM Wouters, Neil K Aaronson, Wim H van Harten. Originally published in JMIR Cancer (http://cancer.jmir.org), 08.08.2017. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Groen, Wim G Kuijpers, Wilma Oldenburg, Hester SA Wouters, Michel WJM Aaronson, Neil K van Harten, Wim H Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title | Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title_full | Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title_fullStr | Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title_full_unstemmed | Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title_short | Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study |
title_sort | supporting lung cancer patients with an interactive patient portal: feasibility study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566630/ https://www.ncbi.nlm.nih.gov/pubmed/28790025 http://dx.doi.org/10.2196/cancer.7443 |
work_keys_str_mv | AT groenwimg supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy AT kuijperswilma supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy AT oldenburghestersa supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy AT woutersmichelwjm supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy AT aaronsonneilk supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy AT vanhartenwimh supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy |